Mild inflammatory activation of mammary arteries in patients with acute coronary syndromes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 6, 2008, Pages

  Foglieni, Chiara ^a,c   Maisano, Francesco ^a   Dreas, Lorella ^b   Giazzon, Alessio ^a   Ruotolo, Giacomo ^a   Ferrero, Elisabetta ^c   Li Volsi, Laura ^a   Coli, Stefano ^a   Sinagra, Gianfranco ^b   Zingone, Bartolo ^b   Alfieri, Ottavio ^a   Becker, Anton E ^a   Maseri, Attilio ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

E selectin; Endothelium; Major histocompatibility complex class I; Major histocompatibility complex class II DR

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE TRANSPORTER 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THROMBOPLASTIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; INTERNAL MAMMARY ARTERY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; VASA VASORUM; ANGINA PECTORIS; ARTERITIS; CHEMISTRY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; IMMUNOLOGY; MAMMARY ARTERY; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION; VASCULAR ENDOTHELIUM;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ARTERITIS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; MALE; MAMMARY ARTERIES; MICROSCOPY, CONFOCAL; MIDDLE AGED; UP-REGULATION; VASA VASORUM;

EID: 49249138357     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91428.2007     Document Type: Article

References (49)

1. Accolla RS, Gross N, Carrel S, Corte G. Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool. Proc Natl Acad Sci USA 78: 4549-4551, 1981.
2. Aird W. Endothelial cell heterogeneity. Crit Care Med 31: S221-S230, 2003.
3. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immun 2: 675-680, 2001.
4. Arbustini E, De Servi S, Bramucci E, Porcu E, Costante AM, Grasso M, Diegoli M, Fasani R, Morbini P, Angoli L. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. Am J Cardiol 75: 675-682, 1995.
5. Becker AE, de Boer OJ, van Der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med 52: 289-297, 2001.
6. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99: 855-860, 1999.
7. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 103: 3062-3068, 2001.
8. Chester AH, Borland JA, Taylor PM, Rose ML, Yacoub MH. Vascular adhesion molecules and immunogenicity in blood vessels used as coronary artery bypass grafts. Eur J Cardiothorac Surg 10: 676-683, 1996.
9. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38: 293-298, 1984.
10. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94: 2013-2020, 1996.
11. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105: 1158-1161, 2002.
12. Eikemo H, Sellevold OF, Videm V. Markers for endothelial activation during open heart surgery. Ann Thorac Surg 77: 214-219, 2004.
13. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 47: C7-C12, 2006.
14. Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R, Properzi G, Desideri G. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des 13: 1631-1645, 2007.
15. Gaudreault N, Scriven DR, Moore ED. Asymmetric subcellular distribution of glucose transporters in the endothelium of small contractile arteries. Endothelium 13: 317-324, 2006.
16. Geissler I, Collins L, Schofield R, Fabre JW. In vivo suppression of major histocompatibility complex class II expression on porcine vascular endothelial cells by an HMG-CoA reductase inhibitor. Transplantation 81: 922-926, 2006.
17. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343: 915-922, 2000.
18. Guray U, Erbay AR, Guray Y, Yilmaz MB, Boyaci AA, Sasmaz H, Korkmaz S, Kutuk E. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 96: 235-240, 2004.
19. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
20. Hollestelle SC, De Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF, Van Middelaar BJ, Pasterkamp G, Quax PH, De Kleijn DP. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109: 393-398, 2004.
21. Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J 33: 450-462, 2003.
22. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201: 319-327, 2003.
23. Ko YS, Yeh HI, Haw M, Dupont E, Kaba R, Plenz G, Robenek H, Severs NJ. Differential expression of connexin43 and desmin defines two subpopulations of medial smooth muscle cells in the human internal mammary artery. Arterioscler Thromb Vasc Biol 19: 1669-1680, 1999.
24. Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly 131: 41-46, 2001.
25. Labarrere CA, Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117: 499-507, 2004.
26. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
27. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331: 417-424, 1994.
28. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianflone D, Liuzzo G, Burzotta F, Crea F, Maseri A. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 109: 3158-3163, 2004.
29. Maehara A, Mintz GS, Bui AB, Walter OR, Castagna MT, Canos D, Pichard AD, Satler LF, Waksman R, Suddath WO, Laird JR Jr, Kent KM, Weissman NJ. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 40: 904-910, 2002.
30. Marx R, Clahsen H, Schneider R, Sons H, Klein RM, Gulker H. Histomorphological studies of the distal internal thoracic artery which support its use for coronary artery bypass grafting. Atherosclerosis 159: 43-48, 2001.
31. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 107: 2068-2071, 2003.
32. Meredith IT, Plunkett JC, Worthley SG, Hope SA, Cameron JD. Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering. Coron Artery Dis 16: 415-422, 2005.
33. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Papa ML, Toscano T, Marullo A, Chiavarelli M. Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina. Circ Res 92: 1359-1366, 2003.
34. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 141: 673-683, 1992.
35. Ribau JC, Hadcock SJ, Teoh K, DeReske M, Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. J Surg Res 85: 225-233, 1999.
36. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106: 804-808, 2002.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
38. Savage CO, Brooks CJ, Harcourt GC, Picard JK, King W, Sansom DM, Willcox N. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol 7: 471-479, 1995.
39. Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, Crea F. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 40: 1579-1588, 2002.
40. Sutherland AJ, Nataatmadja MI, Walker PJ, Cuttle L, Garlick RB, West MJ. Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation 113: 1180-1188, 2006.
41. Toprak V, Sirin BH, Tok D, Ozbilgin K, Saribulbul O. The effect of cardiopulmonary bypass on the expression of inducible nitric oxide synthase, endothelial nitric oxide synthase, and vascular endothelial growth factor in the internal mammary artery. J Cardiothorac Vasc Anesth 20: 63-67, 2006.
42. Turesson C. Endothelial expression of MHC class II molecules in autoimmune disease. Curr Pharm Des 10: 129-143, 2004.
43. Vallbracht KB, Schwimmbeck PL, Seeberg B, Kuhl U, Schultheiss HP. Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies. J Am Coll Cardiol 40: 515-520, 2002.
44. van der Wal AC, Piek JJ, de Boer OJ, Koch KT, Teeling P, van der Loos CM, Becker AE. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 80: 14-18, 1998.
45. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106: 1439-1441, 2002.
46. Verma SL, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105: 1890-1896, 2002.
47. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 86: 2839-2843, 1989.
48. Zembala M, Wojnicz R, Ryfinski B, Piegza J, Kaperczak J, Przybylski R, Gasior M, Zembala M, Kaczmarski J. Inflammatory components in endarterectomy lesions: an immunohistological study. Cardiovasc Surg 10: 203-205, 2002.
49. Zulli A, Hare DL, Horrigan M, Buxton BF. The resistance of the IMA to atherosclerosis might be associated with its higher eNOS, ACE and ET-A receptor immunoreactivity. Arterioscler Thromb Vasc Biol 23: 1308, 2003.